Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04616534
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-09
First Post:
2020-11-04
Brief Title:
Testing the Addition of an Anti-cancer Drug Elimusertib BAY 1895344 ATR Inhibitor to the Chemotherapy Treatment Gemcitabine for Advanced Pancreatic and Ovarian Cancer and Advanced Solid Tumors
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-04
First Submit QC Date:
November 4 2020
Study First Post Date:
2020-11-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-10
Last Update Post Date:
2024-04-09
Last Update Post Date Type:
ACTUAL